---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-022075"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T18:53:56.876131+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience annual meeting results: directors elected, auditor ratified, say-on-pay approved

## Summary
- Cheryl R. Blanchard elected with 22,509,430 votes for, 3,095,043 withheld; Sabrina Martucci Johnson with 23,447,732 for, 2,156,741 withheld.
- Ratification of Mayer Hoffman McCann as auditor for FY2023: 48,270,018 for, 1,341,227 against, 262,151 abstentions.
- Advisory say-on-pay approved: 22,399,824 for, 3,026,516 against, 178,133 abstentions; 24,268,923 broker non-votes.

## SEC filing metadata
- accession: 0001493152-23-022075
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-022075
- JSON: https://secwatch.observer/filing/0001493152-23-022075.json
- Plain text: https://secwatch.observer/filing/0001493152-23-022075.txt

## Key facts
- Shareholder Votes
  Dare Bioscience, Inc. shareholders approved Election of Class III directors at the 2023-06-21 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Each of the director nominees was elected as a Class III director to hold office until our 2026 annual meeting of stockholders, and until a successor is duly elected and qualified, by the votes set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm
- Shareholder Votes
  Dare Bioscience, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2023-06-21 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Our stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement by the votes set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm
- Shareholder Votes
  Dare Bioscience, Inc. shareholders approved Ratification of appointment of Mayer Hoffman McCann P.C. as independent registered public accounting firm at the 2023-06-21 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Our stockholders ratified the appointment of Mayer Hoffman McCann P.C.as our independent registered public accounting firm for the fiscal year ending December 31, 2023 by the votes set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401914/000149315223022075/0001493152-23-022075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.